The data presented at the Type A meeting in September 2023 appears to have changed that:
- CRL in August (data via targeted, controlled study)
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02694227-3A622780
- Type A announcement in September (data via new potency assay)
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02714514-3A626594
- Annual Report to Shareholders in October (confirmation: data via potency assay or clinical data)
https://www.mesoblast.com/images/pdf/MSB_2023_Annual_Report_Online.pdf
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.060(2.55%) |
Mkt cap ! $3.084B | |||
| Open | High | Low | Value | Volume |
| $2.41 | $2.49 | $2.40 | $25.69M | 10.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 32500 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| MSB (ASX) Chart |